David Happel
2023
In 2023, David Happel earned a total compensation of $2.7M as President and Chief Executive Officer at Sagimet Biosciences, a 59% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $329,725 |
|---|---|
| Salary | $502,894 |
| Stock Awards | $1,849,734 |
| Other | $3,564 |
| Total | $2,685,917 |
Happel received $1.8M in stock awards, accounting for 69% of the total pay in 2023.
Happel also received $329.7K in non-equity incentive plan, $502.9K in salary and $3.6K in other compensation.
Rankings
In 2023, David Happel's compensation ranked 355th out of 2,978 executives tracked by ExecPay. In other words, Happel earned more than 88.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 355 out of 2,978 | 88th |
Division Manufacturing | 203 out of 1,637 | 88th |
Major group Chemicals And Allied Products | 140 out of 906 | 85th |
Industry group Drugs | 137 out of 869 | 84th |
Industry Pharmaceutical Preparations | 85 out of 627 | 86th |
Source: SEC filing on April 18, 2024.
Happel's colleagues
We found three more compensation records of executives who worked with David Happel at Sagimet Biosciences in 2023.